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Background: AMP-activated protein kinase (AMPK) is a heterotrimeric serine/threonine protein kinase that is
activated by cellular perturbations associated with ATP depletion or stress. While AMPK modulates the activity
of a variety of targets containing a specific phosphorylation consensus sequence, the number of AMPK targets
and their influence over cellular processes is currently thought to be limited.
Results: We queried the human and the mouse proteomes for proteins containing AMPK phosphorylation consensus
sequences. Integration of this database into Gaggle software facilitated the construction of probable AMPK-regulated
networks based on known and predicted molecular associations. In vitro kinase assays were conducted for preliminary
validation of 12 novel AMPK targets across a variety of cellular functional categories, including transcription, translation,
cell migration, protein transport, and energy homeostasis. Following initial validation, pathways that include NAD
synthetase 1 (NADSYN1) and protein kinase B (AKT2) were hypothesized and experimentally tested to provide a
mechanistic basis for AMPK regulation of cell migration and maintenance of cellular NAD+ concentrations during
catabolic processes.
Conclusions: This study delineates an approach that encompasses both in silico procedures and in vitro experiments
to produce testable hypotheses for AMPK regulation of cellular processes.
Keywords: AMPK, AKT2, ATF2, MMP-2, FOXO3a, NADSYN1, Phosphorylation consensus sequence, Bioinformatics,
Proteome, Network predictionBackground
Maintenance of cellular health requires the orchestration
of multiple metabolic pathways and signaling cascades
whose effects sum to maintain cellular homeostasis.
AMP-activated protein kinase (AMPK) has emerged as a
major regulator of cellular metabolism through activation
of signaling cascades that are protective against stress.
AMPK is composed of three subunits (α, β, and γ), and its
activation occurs via AMP-dependent and -independent
mechanisms leading to phosphorylation of the α subunit* Correspondence: jshyy@ucsd.edu
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unless otherwise stated.at Thr172. While elevation of the AMP: ATP ratio pro-
motes AMP binding to the γ subunit, which permits acti-
vation by LKB1, Ca2+ influx elicits activation by CaMKKβ
independent of the AMP: ATP ratio [1-3]. In addition to
Thr172 phosphorylation a variety of posttranslational
modifications including phosphorylation at sites other
than Thr172 as well as myristolation of the β subunit can
control AMPK activation [4].
Once activated, AMPK initiates an array of signaling
cascades by phosphorylating proteins with a βϕβXXXS/
TXXXϕ consensus sequence (hydrophobic, φ=M, L, I, F, or
V; basic, β=R, K, or H, X = any amino acid, S/T = phos-
phorylation site) [5,6]. AMPK targets often contain slight
variants of this consensus sequence, because AMPK can
phosphorylate sites flanked by amino acid sequences lacking
the basic residues in the −4/-6 positions. Additionally,his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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position [7]. Understanding how AMPK exerts its pro-
tective effects via various signaling pathways requires
knowledge of all of AMPK targets, which may be more
extensive than currently recognized. To explore this pos-
sibility, we mapped its phosphorylation consensus se-
quence to both human and mouse proteomes. Delineation
of AMPK networks involved integration of these data into
Gaggle software to organize putative targets based on func-
tion. Along with knowledge gained from an extensive lit-
erature review, networks were constructed and then used
to predict pathways linking the putative targets [8]. This
approach yielded an extraordinarily large group of putative
AMPK targets and suggested several novel pathways. The
predicted pathways from this approach have the potential
to redefine the role of AMPK as a survival master switch
responding to stress imposed on the cell.
Results and discussion
Bioinformatics and systems biology approach
Initially, we performed an in silico search of the AMPK
phosphorylation consensus sequence to the human and
mouse proteomes. The most stringent AMPK consensus
phosphorylation sequence (i.e., βϕβXXXS/TXXXϕ [5,6])
was queried to the ENSEMBL proteome, which yielded 866
human and 811 mouse putative AMPK targets. Searching
with a less stringent consensus phosphorylation sequenceFigure 1 Bioinformatics screening of putative AMPK substrates. (A) Th
phosphorylation consensus sequence and their integration into functional
phosphorylation sequence containing proteins in various functional categoin the SWISS-PROT proteome, in which β and ϕ were un-
specified, yielded 4505 human and 3158 mouse putative
AMPK targets from over 17,000 peptides. Some putative
targets have multiple potential phosphorylation sites. To
delineate cellular functions regulated by AMPK via these
targets, the resulting databases were imported into Gaggle
software, along with putative target annotations compiled
from an extensive literature review, and then displayed
graphically with Cytoscape software (Figure 1A). This bio-
informatics compilation of proteins containing the AMPK
phosphorylation consensus sequence represents a novel
database for putative AMPK targets and suggests the in-
volvement of AMPK in cellular functions spanning both
top-down (receptor response to stimulus) and bottom-up
perspectives (transcriptional regulation for cellular func-
tions) (Figure 1B). A representative list of potential AMPK
targets is found in Additional file 1: Table S1.
AMPK phosphorylation of NADSYN1 and transactivation
through FOXO3a
We next focused on an array of cellular processes that
appear to be regulated by AMPK for validation and par-
tial pathway delineation. Acting as an energy homeostatic
regulator, AMPK activation should increase NADH levels
necessary for ATP generation through oxidative phosphor-
ylation and prolonged catabolic flux. Cantó et al. reported
that AMPK activation increases cellular NAD+ levelse algorithm used in the identification of proteins containing an AMPK
categories. (B) Pie chart illustrating the representation AMPK consensus
ries.
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(NAMPT), a key enzyme in NAD+ synthesis [9]. Of the
pathways involving NAD+ biogenesis, glutamine-dependent
NAD+-synthetase (NADSYN1) also contributes to main-
taining cellular NAD+ by catalyzing the final step in its bio-
synthesis. NADSYN1 and NAD+ are precursors for many
signaling molecules involved in a variety of cellular pro-
cesses, particularly for redox balance [10]. Furthermore,
AMPK can directly phosphorylate the transcription factor,
forkhead box O3a (FOXO3a), which likely binds to the
NADSYN1 promoter [11]. Given that NADSYN1 contains
an AMPK phosphorylation consensus sequence and its
promoter has a FOXO3a recognition sequence, we hypoth-
esized that AMPK phosphorylates and activates NADSYN1
as well as promotes NADSYN1 transcription through phos-
phorylation of FOXO3a (Figure 2A). In vitro kinase assays
of recombinant NADSYN1 showed that AMPK can phos-
phorylate NADSYN1 (Figure 2B). Elevated AMPK activity
in these assays was evident by AMPK autophosphorylation
(Figure 2B). To demonstrate that AMPK can phosphorylate
the predicted target site at Ser641, we generated a peptide
analogous to the sequence containing Ser641 and its
flanking AMPK phosphorylation consensus sequence
(KVKRFFS641KYSM) and a mutant peptide with Ser toFigure 2 AMPK phosphorylates NADSYN1 at Serine 641. (A) Schematic
panel represents in vitro kinase assay using (γ-32P) ATP, full-length recombinant
panel represents to Coomassie blue (CB) stain to demonstrate equal substrate
kinase assay repeated using NADSYN1 Ser641 and Ser641A peptides (C) o
only (γ-32P) ATP without AMPK nor substrate. AMPK represents reactions
the AMPK phosphorylation site in acetyl CoA carboxylase, serving as a positive
repeated at least 3 times.Ala substitution. In vitro kinase assay in the presence of
AMPK showed increased 32P incorporation to the S641
peptide and SAMS peptide, a 13-residue peptide with a
sequence around the AMPK target on acetyl CoA carb-
oxylase and the standard positive control for AMPK
kinase activity [5] (Figure 2C). The level of 32P incorpo-
rated into the S641A peptide was much lower, which
was comparable to background or reaction without pep-
tide. Similar results were obtained with the use of full
length recombinant NADSYN1 (Figure 2D). Next, we in-
vestigated whether AMPK regulates NADSYN1 transacti-
vation through phosphorylation of FOXO3a. Chromatin
immunoprecipitation (ChIP) assays revealed that AICAR,
an AMPK agonist, increased the binding of FOXO3a to
the NADSYN1 promoter with a corresponding increase in
the level of NADSYN1 mRNA in C2C12 cells (Figures 3A,
3B), which were attenuated if AMPK or FOXO3a were
knocked down by siRNA. Additionally, AICAR increased
the level of phosphorylated FOXO3a and NADSYN1 in
AMPK+/+, but not AMPK−/− mouse embryonic fibroblasts
(MEFs) (Figure 3C). We also verified AMPK phosphoryl-
ation of NADSYN1 by using C2C12 cells, which are a
mouse muscle cell line. Likewise, AICAR increased
NADSYN1 expression and FOXO3a phosphorylationof AMPK phosphorylation and transactivation of NADSYN1. (B) Bottom
NADSYN1 without (left) and with recombinant (right), active AMPK. Top
protein loading. Scintillation counter per minute (CPM) quantification of
r full length NADSYN1 (D). Background represents reactions with
with AMPK, (γ-32P) ATP, but no substrate. SAMS is a peptide containing
control. Student t-test used to determine *p < 0.5, all experiments were
Figure 3 AMPK activation increases the expression and activity of NADSYN1. (A) ChIP assay illustrating the level of FOXO3a binding to
the NADSYN1 promoter following treatment with AMPK activator, 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR, 1 mM), for
8 h. (B) qRT-PCR results illustrating the NADSYN1 mRNA abundance following transfection with control, AMPK, or FOXO3a siRNA and then
treated with AICAR or left untreated. (C) Immunoblot of AMPK+/+ and AMPK−/− MEFs transfected with control, AMPK, or FOXO3a siRNA and
treated with AICAR or left untreated. (D) Immunoblotting of lysates from cells transfected with control, AMPK, or FoxO3a siRNA then treated
with or without AICAR. [NAD+] measured in AMPK+/+ and AMPK−/− MEFs (dashed line represents CTRL no treatment) (E) or C2C12 cells
(F) transfected with control, AMPK, or NADSYN1 siRNA and treated with AICAR with or without the NAMPT inhibitor FK688. Data analyzed
using Wilcoxon signed-rank test or Mann–Whitney U test. *p < 0.05, all experiments were repeated at least 3 times.
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ished when AMPK or FOXO3a were knocked down.
Next, we investigated how NADSYN1 activity is affected
by AMPK phosphorylation. As illustrated in Figure 3E, the
AMPK+/+ MEFs had a higher level of [NAD+] compared to
AMPK−/− MEFs, which was attenuated when NADSYN1
was knocked down. In addition to NADSYN1, NAMPT is
also a source of intracellular NAD+. Following transfection
with control, AMPK, or NADSYN1 siRNA, C2C12 cells
were treated with AICAR in the presence or absence of
FK688, a pharmacological inhibitor of NAMPT, and the
[NAD+]/[NADH] ratio was measured. While AMPK acti-
vation by AICAR increased the cellular [NAD+], NAD-
SYN1 or AMPK knocked down attenuated this increase
(Figure 3F). Taken together, these results suggest that
AMPK phosphorylates NADSYN1 to prolong NAD+
production, while concurrently increasing NADSYN1
transactivation through phosphorylation of FOXO3a.
Because of the involvement of AMPK, FOXO3a, and
[NAD+] in regulating cellular energy status, this pro-
posed pathway can be used to test hypotheses involvingAMPK’s regulated metabolic pathways during energy con-
suming processes such as cell migration or angiogenesis.
AMPK activation increases cell migration through the
AKT2-ATF2-MMP-2 pathway
AMPK is involved in a variety of stress responses of vascu-
lar endothelial cells (ECs) such as cell migration and
angiogenesis, both of which require prolonged metabolic
flux to achieve energy homeostasis. For example, AMPK
positively regulates EC migration and differentiation facili-
tating angiogenesis under hypoxia [12,13]. With our phos-
phorylation consensus sequence database, we assembled a
subgroup of putative AMPK targets involved in angiogen-
esis. Within this subgroup, we chose AKT2 for analysis
because AKT2 phosphorylates activating transcription
factor 2 (ATF2) [14,15]. In turn, phosphorylated ATF2
transcriptionally regulates matrix metalloproteinase-2
(MMP-2) causing matrix degradation and cell migra-
tion [16,17], as summarized in Figure 4A. Given that
AKT2 Ser268 is a putative AMPK phosphorylation site,
we performed kinase assays and quantified the level of
Figure 4 AMPK phosphorylation of AKT2 at Serine 268. (A) Schematic of AMPK regulation of EC migration through AKT2 phosphorylation.
(B) Bottom panel represents in vitro kinase assay using (γ-32P) ATP and full-length recombinant AKT2 in the presence or absence of AMPK. Top
panel represents CB staining for equal loading of recombinant AKT2. (C,D) CPM quantification of kinase assay using AKT2 Ser268 and Ser268A
peptides (C) or full-length AKT2 (D). The experimental conditions were the same as those in Figure. 2. Student t-test used to determine *p < 0.5,
all experiments were repeated at least 3 times.
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(Figures 4B, 4D) and peptides analogous to a sequence
around Ser268 that includes the AMPK phosphoryl-
ation consensus sequence (LEYLHS268RDVV) or a pep-
tide with an alanine substituted for the serine to
support AMPK phosphorylation of AKT2 at Ser268
(Figure 4C). Next, we conducted ChIP assays to deter-
mine if AMPK phosphorylation of AKT2 increases
ATF2 binding to the MMP-2 promoter. ECs treated
with AICAR had an increased level of ATF2 interacting
with the MMP-2 promoter but not if AMPK or AKT2
were knocked down (Figure 5A). Furthermore, AICAR
treatment increased MMP-2 mRNA levels, which were
attenuated if the cells were transfected with AMPK,
AKT2, or ATF2 siRNA (Figure 5B). Additionally, MMP-2
protein levels also increased with AICAR treatment in
ECs transfected with control RNA, but not in cells trans-
fected with AMPK or AKT2 siRNA (Figure 5C). Immuno-
blotting further revealed that AICAR increased MMP-2
expression and phosphorylation of ATF2 in AMPK+/+ but
not in AMPK−/− MEFs (Figure 5D). Next, we tested if
AMPK regulates the activity of MMP-2. As illustrated in
Figure 5E, AMPK activation by AICAR increased MMP-2
activity but not if the cells were transfected with AMPK,
AKT2 or ATF2 siRNA. We then conducted in vitro
wound-closure assays to elucidate the effect of the AMPK/AKT2/ATF2/MMP-2 signaling cascade on EC migration
and model wound healing. Cells treated with AICAR
showed enhanced cell migration into the scratched zone,
which was attenuated if AMPK, AKT2, or ATF2 were
knocked down (Figures 5F, 5G). Taken together, these data
suggest that AMPK regulates EC migration through phos-
phorylation of AKT2, which promotes ATF2 transactiva-
tion of MMP-2 during EC migration.
Identification of novel AMPK substrates and signaling
networks for future study
After assembling a list of proteins containing the AMPK
phosphorylation consensus sequence, the resulting data-
base was integrated into Gaggle software to gain an un-
derstanding of the subcellular systems or functional
categories that the identified targets represent. We also
utilized this software to determine the number of connec-
tions each target has with other proteins. Central node
substrates were identified as proteins with a high level in-
terconnectivity within a functional category, which indi-
cates a greater influence a protein has on a phenotypic
response. Highly connected nodes were chosen for further
validation as AMPK targets using kinase assays. Predicted
phosphorylation sequences of the identified proteins
chosen are illustrated in Figure 6A. Kinase assays demon-
strate AMPK can phosphorylate these full length proteins
Figure 5 AMPK activation regulates EC migration through transactivation of MMP-2. (A) ChIP analysis illustrating the level of ATF2 binding
to the MMP-2 promoter in HUVECs transfected with control, AMPK, or AKT2 siRNA, then treated with AICAR (1 mM). Results are expressed as fold
change. (B) HUVECs were transfected with control, AMPK, AKT2, or ATF2 siRNA and treated with AICAR prior to quantifying MMP-2 mRNA abundance
with qRT-PCR. Immunoblot analysis and densitometry of MMP-2 and ATF2 (phosphorylated and total) in (C) HUVECs transfected with control, AMPK, or
AKT2, siRNA or (D) AMPK+/+ and AMPK−/− MEFs treated with AICAR or left untreated. (E) HUVECs were transfected with control, AMPK, AKT2, or ATF2
siRNA and then treated with AICAR or left untreated for 8 h prior to analyzing the level of MMP-2 activity. (F) Scratch assay with confluent ECs transfected
with control, AMPK, AKT2, or ATF2 siRNA followed by scratch induction then treated with AICAR or left untreated for 8 hr prior to imaging and quantifying
EC migration (G). Data analyzed using Wilcoxon signed-rank test or Mann–Whitney U test. *p < 0.05, all experiments were repeated at least
3 times.
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networks illustrating the outcome AMPK phosphoryl-
ation of each substrate may have. Additional file 2:
Figure S1 illustrates graphically how these substrates
could be involved in various cellular functions.
G protein coupling to the seven-transmembrane receptor
(GPCRs) activity
Beta Arrestin 1 (ARRB1) regulates many signaling cas-
cades through steric hindrance of GPCRs and serves as
a scaffold for several AMPK regulated signaling mole-
cules, including extracellular-signal-regulated kinases
1/2 (ERK1/2) and nuclear factor kappa-light-chain-en-
hancer of activated B cells (NFκB) [18,19]. Additionally,
it participates in transactivation of c-fos and p27 byrecruiting histone acetyltransferases, such as p300,
which correlates with conditions that activate AMPK
[20-22]. Thus, AMPK’s regulation of these signaling
pathways could be mediated through ARRB1 phos-
phorylation (Additional file 2: Figure S1A).
5’-terminal oligopyrimidine (TOP) regulation
DDX56, also known as nucleolar helicase of 61 kDa
(NOH61), is a putative RNA helicase implicated in a
number of cellular processes involving alteration of
RNA secondary structure [23]. DDX56 is a constituent
of free nucleoplasmic 65S preribosomal particles and
seems to be necessary for ribosome synthesis at the
level of large (60S) ribosomal subunit assembly [23].
Transcriptional inhibitors, such as actinomycin D, cause
Figure 6 Kinase assays and predicted phosphorylation sequence of representative AMPK targets. (A) AMPK phosphorylation consensus
sequence. Blue represents basic amino acids, orange represents hydrophobic amino acids, and red represents phosphorylated amino acids.
(B-D) Coomassie blue staining (CB) and autoradiography of in vitro kinase assays without (left) and with activated AMPK (right), (γ-32P) ATP, and
full-length recombinant substrates. Arrow (→) indicates substrate. Each panel is accompanied by the control kinase assay that contained only
recombinant, active AMPK and (γ-32P) ATP to identify relative position of autophosphorylated AMPK subunits.
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nents [23]. All vertebrate genes encoding for the riboso-
mal proteins contain TOP [23]. Interestingly, exercise-
activated AMPK is accompanied by decreased translation
of TOP containing genes [24]. Although the mechanism
by which activated AMPK represses the translation of
ribosomal proteins is unclear, it would be independent of
ribosomal protein S6 kinase or ribosomal protein S6 (rpS6)
phosphorylation, both of which are known to regulate
translation [25]. One possibility is that AMPK decreases
the translation of TOP genes through phosphorylation of
DDX56 and in turn attenuates the functions related to
TOP genes in the nucleolus (Additional file 2: Figure S1B).
Endoplasmic reticulum (ER) stress and calcium homeostasis
Calnexin (CALNX) is a type I integral ER transmembrane
chaperone that transiently binds to the newly synthesized
glycoproteins to assist in their folding and transport [26].
Because ER stress is hallmarked by elevated levels of un-
folded organelle proteins [27], CALNX has been suggested
to be a key protective component of the unfolded protein
response (UPR)/ER stress response, which activates
protein folding/transport chaperones, while decreasing
protein synthesis [28]. Through phosphorylation of its
cytoplasmic domain, CALNX also regulates sarco/endo-
plasmic reticulum calcium ATPase (SERCA) 2b, regulatingCa2+ signaling and Ca2+-sensitive chaperone functions in
the ER [29]. This phosphorylation event prevents the in-
hibition of SERCA and the subsequent Ca2+ efflux to
cause ER stress [30]. Although AMPK decreases SERCA
oxidation, maintaining its activity and intracellular Ca2+
homeostasis [31], the mechanism for this is unknown.
Our analyses suggest that AMPK regulation of Ca2+ and
SERCA activity could be through phosphorylation of
CALNX Ser-247 and/or Thr-93, functioning as a protect-
ive mechanism (Additional file 2: Figure S1C).
Insulin signaling and glucose transport
High-mobility group AT-hook 1 (HMGA) is a transcrip-
tional regulator that preferentially binds to the minor
groove of A/T-rich regions in double-stranded DNA to
form transcriptionally active multiprotein-DNA complexes
that regulate the expression of target genes such as the
insulin receptor (IR) [32]. HMGA1, through AMPK-
caveolin-1 (Cav-1) signaling, can also potentiate the re-
cruitment of transcriptional complexes to the solute
carrier family 2 and glucose transporter member 3
(SLC2A3/Glut3) promoters [33]. Importantly, Cav-1 ex-
pression is necessary for metformin induction of AMP
binding and activation of AMPK [34]. These observa-
tions suggest that the Cav-1/AMPK/HMGA1 signaling
pathway is involved in the transcriptional regulation of
Marin et al. BMC Systems Biology  (2015) 9:13 Page 8 of 12genes important for insulin signaling and glucose trans-
port (Additional file 2: Figure S1D).
Smooth muscle cell (SMC) recruitment and vasculogenesis
Krüppel-like Factor 2 (KLF2) is a transcription factor
that regulates diverse biological processes by direct DNA
binding or association with transcription co-regulators
such as acetyltranferases, cAMP response element bind-
ing protein (CREBP), and p300 [35-37]. KLF2 is highly
expressed in ECs during embryonic development [38].
Klf2 genetic knockout results in defective recruitment of
pericytes and vascular SMCs, impaired vasculogenesis,
and lethality [39]. The mechanism by which KLF2 re-
cruits SMCs is poorly understood. Lysophosphatidic acid
(LPA) and its receptor, LPA4, are mediators of SMC re-
cruitment in vasculogenesis. Interestingly, the LPA4 pro-
moter contains a KLF2 binding site [40]. Given that AMPK
activation promotes KLF2 expression [41], AMPK may
modulate KLF2 transcriptional activity to increase LPA4 ex-
pression (Additional file 2: Figure S1E). Our analysis sug-
gests that AMPK phosphorylation of KLF2 might provide
an additional mode of regulation such as enhanced protein
stability, altered protein-protein/protein-nucleic acid inter-
actions, or increased transcriptional specificity.
Ribosomal biogenesis
Treacle, commonly referred to as TCOF, is a nucleolar
protein involved in ribosomal gene transcription. TCOF
interacts with upstream binding factor (UBF) and pro-
moter selectivity factor SL1 to promote RNA polymerase
I activity [42,43]. TCOF deficiency results in poor neural
crest formation and proliferation due to neuroepithelial
apoptosis as a consequence of decreased expression of
28s ribosomal subunit of rRNA, which ultimately results
in the expression of genes important for structural de-
velopment [44]. Although the role of AMPK in regulat-
ing protein synthesis is generally believed to be negative,
AMPKα1 and α2 null embryos are lethal ~10.5 days
post-conception because of poor expression of genes im-
portant for growth and survival [45]. If AMPK indeed
regulates TCOF expression, it may prevent aberrant pro-
tein synthesis allowing normal embryonic development
(Additional file 2: Figure S1F).
Epigenetics
Charged multivesicular body protein 1B (CHMP1b) also
plays a role in gene regulation through chromatin struc-
tural maintenance [46]. CHMP1b associates with nuclease-
resistant, condensed chromatin and the polycomb-group
(PcG) proteins, which are required for maintenance of
gene silencing during development. CHMP1b induction
causes cell-cycle arrest and increased S-phase cell num-
ber [47]. However, CHMP1b also forms a shell around
chromatin that frequently is associated with histone H3phosphorylation and acetylation regulating transcriptional
activity [47,48]. The phosphorylation of CHMP1b by
AMPK could play a role in the transition of active and in-
active chromatin domains and therefore determination of
heritable epigenetic marks (Additional file 2: Figure S1G).
mRNA processing and translation
Cleavage and polyadenylation specificity factor 2 (CPSF2)
is the 100-kDa subunit of the CPSF that recognizes the
AAUAAA consensus sequence and interacts with proteins
such as the poly (A) polymerase to prompt cleavage of
template mRNA and initiation of poly (A) addition in pre-
mRNA 3'-end formation [49]. This process inhibits mature
mRNA degradation and activates translation [49]. Under
stress, AMPK phosphorylation of CPSF2 may increase the
association of CPSF2 with the CPSF complex, thus direct-
ing CPSF’s recognition of the AAUAAA sequence
(Additional file 2: Figure S1H). As a result of this
process, AMPK could increase the translation of genes ne-
cessary for stress resistance. Alternatively, AMPK could
inhibit this process causing the degradation of genes that
are involved in excessive energy expenditure.
Cell cycle and circadian rhythm
Nuclear casein kinase and cyclin-dependent kinase sub-
strate 1 (NUCKS1) is a substrate for casein kinase and
cyclin-dependent kinase (CDK) and its phosphorylation
is important for cell-cycle regulation [50]. Upon mitosis,
DNA-bound NUCKS1 translocates from the nucleus to
the cytoplasm [51]. Aberrant overexpression of NUCKS1
is correlated with breast carcinomas [50,51]. Import-
antly, cancer is highly associated with disrupted cellular
circadian rhythm, which serves to regulate positive and
negative transcriptional feedback loops. Both casein kinase
and CDK are key regulators of cellular circadian rhythm
as is AMPK [52,53]. Thus, AMPK could regulate circadian
rhythm through phosphorylation of NUCKS1 (Additional
file 2: Figure S1I).
Chromatin structure and protein folding
Zuotin-related factor 1 (ZRF1) executes both cytosolic
and nuclear functions. In the nucleus, ZRF1 binds to the
DNA sequence: 5’-GTCAAGC-3’ and facilitates histone
2A K119 ubiquitination leading to chromatin remodeling
and transcription activation [54]. In the cytoplasm, ZRF1,
by stimulation of the ATPase activity of heat shock
70 kDa protein A14 (HSPA14) chaperones, acts as a mo-
lecular chaperone to promote protein folding of the nas-
cent polypeptide chain as it exits the ribosome [55,56].
The phosphorylation of ZRF1 by AMPK may result in
dissociation of ZRF1 from the ribosome leading to its nu-
clear accumulation (Additional file 2: Figure S1J). Thus, this
pathway putatively regulated by AMPK would participate
in epigenetic remodeling of promoters of target genes.
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AMPK has emerged as a master regulator of metabolism
by serving as an energy sensor. However, the multiple
modes of AMPK activation, many of which remain elu-
sive, indicate that AMPK’s function may extend beyond
a mere energy sensor. Here, our in silico database to-
gether with biological validations suggests that AMPK is
a master regulator of a broader range of cellular processes
at more levels than previously recognized. Identifying
AMPK targets by phosphorylation consensus sequence
mapping is a simplification of the biochemistry that occurs
at the substrate-enzyme interface because tertiary struc-
ture and binding domain chemistry is important for kinase
substrate specificity and accessibility. However, arguably,
the constraints of the active site require a minimum signa-
ture sequence within the catalytic pocket that mirrors a
chemical signature flanking the phosphorylation site for
catalysis to occur [57]. Although in silico screening of the
phosphorylation consensus sequence for candidate sub-
strates of a kinase is a useful tool, the presence of such a
phosphorylation consensus sequence in a given protein
does not necessitate its phosphorylation in the cell. Fur-
ther, some predicted AMPK targets offer slight variation
to the exact consensus sequence, which presents a limita-
tion of in silico analysis. Clearly, additional validation of
individual targets and networks is necessary. Several bio-
chemical tools are available and essential for such valid-
ation including in vitro kinase assays using recombinant
protein substrates and phospho-antibodies for cellular and
in vivo studies. Additional levels of AMPK phosphoryl-
ation specificity can be achieved with AMPK α1 and α2
knockout MEF cells and conditional knockout mice fol-
lowing treatment with AMPK agonists/activators such as
exercise, caloric restriction, metformin, and AICAR. This
database provides investigators with an AMPK-related
network development tool that should stimulate experi-
mental validation and offers new insights into AMPK in-
volvement in health and disease.
Methods
Bioinformatics approach
Using an R script, the AMPK phosphorylation consensus
sequence, βϕβXXXS/TXXXϕ (where hydrophobic, φ =M,
L, I, F, or V; basic, β =R, K, or H, X = any amino acid, S/T =
phosphorylation site) was mapped to human and mouse
proteomes imported from ENSEMBL proteome database
[5-7]. To find the proteins containing an AMPK phosphoryl-
ation consensus sequence, each peptide sequence obtained
from the R script mapping was individually pasted into the
BLAST algorithm provided by NCBI (http://www.ncbi.nlm.
nih.gov/sutils/blink.cgi?mode=query). Using the less strin-
gent consensus phosphorylation sequence, in which φ and β
were not specified to be a specific amino acid, a Scansite
search was also performed to compare with the ENSEMBLsearch to the SWISS-PROT protein database [5-7]. The gen-
erated databases were integrated into Gaggle software to
predict and display pathways involving AMPK [9].
Kinase assays
AMPK kinase assays were performed using full-length re-
combinant proteins in 50 mM HEPES (pH 7.4), 1 mM
AMP, 1 mM (γ-32P) ATP, 5 mM MgCl2, 1 pM AMPK
(Sigma Aldrich), and the putative target recombinant pro-
tein (1 nM) in a 50 μl reaction volume at 37°C for 1 h.
Proteins were then resolved by using SDS-PAGE, stained
with Coomassie blue, and subjected to autoradiographic
analysis. Peptide assays were performed under the same
conditions but with 3 nM peptide, (γ-32P) ATP 1 mM, and
1 pM AMPK. SAMS peptide (3 nM) was used as positive
control. Peptide reactions were terminated by blotting
samples onto Whatman grade P81 ion-exchange chroma-
tography paper, rinsed in 1% phosphoric acid, washed in
acetone, and allowed to air dry prior to submersion in
1 ml scintillation fluid. The radioactivity was measured
with a Beckman LS 6500 scintillation counter.
Cell lines
MEF cells were isolated from mice according to standard
protocols [58]. HUVEC and C2C12 cells were purchased
from American Type Culture Collection (ATCC) Cat#
CRL-1730 and CRL-1772 respectively.
siRNA knockdown of gene expression
siRNA knockdown was conducted according to standard
protocols. The following human siRNA sequences were
used from Qiagen: Scrambled, AMPK, AKT2, and ATF2,
Cat# 1022076, SI00086359, SI00305872, SI00305872 re-
spectively. The following mouse siRNA sequences were
used from Qiagen: AMPK, FOXO3a, and NADSYN1,
cat# SI01388219, SI01005207, and GS78914 respectively.
Chromatin immunoprecipitation (ChIP) assay
Cells were incubated in 0.75% paraformaldehyde and har-
vested in FA lysis buffer (50 mM HEPES-KOH, pH 7.5,
140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% so-
dium deoxycholate, 0.1% SDS and Halt Protease inhibi-
tors) prior to sonication with a Bioruptor 200. Protein was
immunoprecipitated overnight at 4°C, washed with wash
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, pH 8.0,
150 mM NaCl, 20 mM Tris–HCl (pH 8.0) and eluted
with 100 μl elution buffer (1% SDS, 100 mM NaHCO3).
DNA was purified using Qiagen PCR purification kit prior
to qPCR analysis. The following primers were used for
qPCR analysis of immunoprecipitated DNA: NAD-
SYN1 promoter forward, ATTCCTTGGCTTCCTACT
GC; NADSYN1 promoter reverse, GTGTCTTGATA
GATGGGCTACAG; MMP-2 promoter forward, GC
Marin et al. BMC Systems Biology  (2015) 9:13 Page 10 of 12AGAAGGAAAGAGGTAAGGAAG; MMP-2 promoter
reverse, GAAGGAATGGTCAGAAACAGATG.Quantitative real-time PCR (qRT-PCR)
RNA was purified using TRIzol reagent from Life Tech-
nologies. Two ng of RNA was converted to cDNA using
Promega reverse transcriptase according to the manufac-
turer’s instructions. cDNA was then quantified via qPCR
using SYBER green qPCR master mix from Bio-Rad. Re-
sults were calculated using the delta-delta ct method.





Cells were lysed in 10 mM Tris (pH 7.4), 0.1 M NaCl,
1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM
Na4P2O7, 2 mM sodium orthovanadate (Na3VO4), 0.1%
SDS, 0.5% Sodium Deoxycholate, 1% Triton X-100, 10%
Glycerol, 1 mM PMSF and protease inhibitors. The ob-
tained cell lysates were then resolved by 10% SDS-
PAGE, blocked with 5% milk, rinsed with TBST, probed
with NADSYN, FOXO3a, β-actin, AMPK, MMP2, ATF2
primary antibodies from ABcam cat# ab139561, ab12162,
ab8227, ab110036, ab86607, and ab47476 respectively,
P-FOXO3a and P-ATF2 primary antibodies from Cell
Signaling (Cat # 8174 and 9221), and secondary anti-
bodies (Cat# 7074S and 7076S). The blotted proteins
bands were made detectable by Emerson chemilumin-
escence substrate (ECL) and image captured on HyBlot
CL autoradiography film.MMP-2 assay
MMP-2 activity was determined using Amersham Matrix
Metalloproteinase-2 (MMP-2) Biotrak Activity Assay
System RPN2631 protocol.NADSYN1 assay
The cellular concentration of NAD+ was measured in
C2C12 cell lysates using EnzyChromTM NAD+/NADH
Assay Kit (E2ND-100) and protocol from BioAssay
Systems.Statistical analysis
Data are expressed as means ± SEM of at least three in-
dependent experiments. Comparisons of mean values
between two groups were evaluated using a two-tailed Stu-
dent’s t-test, Wilcoxon signed-rank test or Mann–Whitney
U test. Unless otherwise indicated, *p < 0.05 was considered
statistically significant.Additional Files
Additional file 1: Table S1. Putative AMPK substrates. Additional file 1:
Table S1 contains a representative list of putative AMPK substrates along
with their official symbols, official names, cellular locations, and functions.
Additional file 2: Figure S1. Predicted modules of AMPK phosphorylated
substrates and the related functions. (A) AMPK phosphorylation of ARRB1
inhibits GPCR signaling and increases histone acetylation activity at c-Fos and
p27 promoters. (B) AMPK phosphorylation of DDX56 TOP gene translation
and subsequent 60S ribosomal biogenesis. (C) AMPK phosphorylation of
Calnexin acts a chaperone to positively regulate ER Ca2+ efflux through
SERCA2b. (D) AMPK phosphorylation of HMGA1 increases INSR and
Glut3 transcription through the Cav-1/AMPK pathway. (E) AMPK
phosphorylation of KLF2 increases LP4R transcription and SMC recruitment.
(F) AMPK phosphorylation of Treacle associates with UBF to increase
AMPK-related gene transcription. (G) AMPK phosphorylation of CHMP1b
facilitates lysosomal recycling of proteins and increases S1 cell cycle
arrest. (H) AMPK phosphorylation of CPSF2 increases translation of AMPK
related genes. (I) AMPK phosphorylation of NUCKS transcriptionally regulates
the circadian rhythm. (J) AMPK phosphorylation of ZRF1 inhibits ATPase
activity but increases transcription of AMPK-related genes.
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